Vertex Pharmaceuticals (VRTX) Change in Inventory (2011 - 2026)

Vertex Pharmaceuticals' Change in Inventory history runs 16 years deep, the most recent figure standing at $97.7 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 41.53% year-over-year to $97.7 million in Q1 2026; TTM through Mar 2026 was $454.8 million, a 24.74% decrease from a year earlier, with the FY2025 full-year figure at $524.2 million, up 1.33% from the prior year.
• Change in Inventory grew to $97.7 million in Q1 2026 per VRTX's latest filing, from $77.4 million in the prior quarter.
• Across five years, Change in Inventory topped out at $182.5 million in Q3 2024 and bottomed at -$2.0 million in Q1 2022.
• The 5-year median for Change in Inventory is $82.6 million (2023), against an average of $94.0 million.
• Across the five-year window, Change in Inventory sank 108.77% in 2022 and jumped 4230.0% in 2023, its largest moves.
• Year by year, Change in Inventory stood at $78.3 million in 2022, then dropped by 10.6% to $70.0 million in 2023, then soared by 110.71% to $147.5 million in 2024, then sank by 47.53% to $77.4 million in 2025, then increased by 26.23% to $97.7 million in 2026.
• Per Business Quant, the three latest VRTX Change in Inventory figures stand at $97.7 million (Q1 2026), $77.4 million (Q4 2025), and $131.1 million (Q3 2025).